237 related articles for article (PubMed ID: 29253581)
1. Access to long-acting reversible contraception among US publicly funded health centers.
Bornstein M; Carter M; Zapata L; Gavin L; Moskosky S
Contraception; 2018 May; 97(5):405-410. PubMed ID: 29253581
[TBL] [Abstract][Full Text] [Related]
2. Four aspects of the scope and quality of family planning services in US publicly funded health centers: Results from a survey of health center administrators.
Carter MW; Gavin L; Zapata LB; Bornstein M; Mautone-Smith N; Moskosky SB
Contraception; 2016 Oct; 94(4):340-7. PubMed ID: 27125894
[TBL] [Abstract][Full Text] [Related]
3. Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.
Morgan IA; Zapata LB; Curtis KM; Whiteman MK
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):402-408. PubMed ID: 30731216
[TBL] [Abstract][Full Text] [Related]
4. Access to contraception in local health departments, four Midwest states, 2017-2018.
Satterwhite CL; French V; Allison M; Honderick T; Ramaswamy M
Contraception; 2019 Jun; 99(6):363-367. PubMed ID: 30871935
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing the provision of long-acting reversible contraception in California.
Biggs MA; Harper CC; Malvin J; Brindis CD
Obstet Gynecol; 2014 Mar; 123(3):593-602. PubMed ID: 24499746
[TBL] [Abstract][Full Text] [Related]
6. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
[No Abstract] [Full Text] [Related]
7. Availability of long-acting reversible contraceptives in Los Angeles County clinics through a Medicaid state plan amendment program.
Natavio M; Blotky E; Van Horn CM; Waters C; Ihenacho U; Silverstein E; Cortessis VK; Nelson AL
Contraception; 2018 Dec; 98(6):471-475. PubMed ID: 30076832
[TBL] [Abstract][Full Text] [Related]
8. Provision of long-acting reversible contraception in HIV-prevalent countries: results from nationally representative surveys in southern Africa.
Morse J; Chipato T; Blanchard K; Nhemachena T; Ramjee G; McCulloch C; Blum M; Saleeby E; Harper CC
BJOG; 2013 Oct; 120(11):1386-94. PubMed ID: 23721413
[TBL] [Abstract][Full Text] [Related]
9. Referral Practices Among U.S. Publicly Funded Health Centers That Offer Family Planning Services.
Carter MW; Robbins CL; Gavin L; Moskosky S
J Womens Health (Larchmt); 2018 Aug; 27(8):994-1000. PubMed ID: 29377754
[TBL] [Abstract][Full Text] [Related]
10. Vital signs: trends in use of long-acting reversible contraception among teens aged 15-19 years seeking contraceptive services—United States, 2005-2013.
Romero L; Pazol K; Warner L; Gavin L; Moskosky S; Besera G; Loyola Briceno AC; Jatlaoui T; Barfield W;
MMWR Morb Mortal Wkly Rep; 2015 Apr; 64(13):363-9. PubMed ID: 25856258
[TBL] [Abstract][Full Text] [Related]
11. Community health worker promotions increase uptake of long-acting reversible contraception in Rwanda.
Mazzei A; Ingabire R; Mukamuyango J; Nyombayire J; Sinabamenye R; Bayingana R; Parker R; Tichacek A; Easter SR; Karita E; Allen S; Wall KM
Reprod Health; 2019 Jun; 16(1):75. PubMed ID: 31164155
[TBL] [Abstract][Full Text] [Related]
12. Meeting the contraceptive needs of teens and young adults: youth-friendly and long-acting reversible contraceptive services in U.S. family planning facilities.
Kavanaugh ML; Jerman J; Ethier K; Moskosky S
J Adolesc Health; 2013 Mar; 52(3):284-92. PubMed ID: 23298980
[TBL] [Abstract][Full Text] [Related]
13. Onsite provision of specialized contraceptive services: does Title X funding enhance access?
Thiel de Bocanegra H; Cross Riedel J; Menz M; Darney PD; Brindis CD
J Womens Health (Larchmt); 2014 May; 23(5):428-33. PubMed ID: 24405313
[TBL] [Abstract][Full Text] [Related]
14. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
Davis SA; Braykov NP; Lathrop E; Haddad LB
J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
[TBL] [Abstract][Full Text] [Related]
15. Accessibility of long-acting reversible contraceptives (LARCs) in Federally Qualified Health Centers (FQHCs).
Beeson T; Wood S; Bruen B; Goldberg DG; Mead H; Rosenbaum S
Contraception; 2014 Feb; 89(2):91-6. PubMed ID: 24210278
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional assessment of government health center needs to implement long-acting reversible contraception services in rural Rwanda.
Mazzei A; Ingabire R; Karita E; Mukamuyango J; Nyombayire J; Parker R; Tichacek A; Allen S; Wall KM
BMC Womens Health; 2021 Dec; 21(1):411. PubMed ID: 34911535
[TBL] [Abstract][Full Text] [Related]
17. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
[TBL] [Abstract][Full Text] [Related]
18. The Availability and Use of Postpartum LARC in Mexico and Among Hispanics in the United States.
Potter JE; Hubert C; White K
Matern Child Health J; 2017 Sep; 21(9):1744-1752. PubMed ID: 27562799
[TBL] [Abstract][Full Text] [Related]
19. Access to public transportation and health facilities offering long-acting reversible contraceptives among residents of formal and informal settlements in two cities in Kenya.
Escamilla V; Calhoun L; Odero N; Speizer IS
Reprod Health; 2019 Nov; 16(1):161. PubMed ID: 31703700
[TBL] [Abstract][Full Text] [Related]
20. Implementing best practices for the provision of long-acting reversible contraception: a survey of obstetrician-gynecologists.
Castleberry NM; Stark L; Schulkin J; Grossman D
Contraception; 2019 Aug; 100(2):123-127. PubMed ID: 30981843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
